Sabina, E., Zaidul, I.S.M., Ghafoor, Kashif, Jaffri, J.M., Sahena, F., Babiker, E.E., Perumal, V., Hamed, M., Amid, M., and Khatib, A.
Phaleria macrocarpa is an herbal plant used in Malaysia to enhance vitality. The aim of this study was to screen the α-glucosidase inhibitory activity of different parts (fruit flesh, leaves and stem) of P . macrocarpa. Methanol (polar) and n-hexane (nonpolar) extracts, obtained by room temperature solvent extraction, were evaluated for in vitro α-glucosidase activity inhibition. The compounds were identified by using gas chromatography-mass spectrometry ( GC- MS) according to their similarity index of >70%, which might be responsible for α-glucosidase inhibitory activity. The methanol extract of the fruit flesh had the highest yield (25.6 ± 0.5%), whereas the n-hexane extract of the stem is more effective against α-glucosidase activity ( IC50 0.8 ± 0.1 μg/mL). The fruit flesh ( IC501.3 ± 0.2 μg/mL) and leaves ( IC501.6 ± 0.6 μg/mL) had also well effectively. The identified metabolites are predominantly phenolics, carbohydrates, triterpenes and organic acids, such as D-fructose, squalene, α-linolenic acid and α- D-glucopyranoside. In-depth chemical profiling using GC- MS was performed for the first time for this plant to assess the likely compounds present in the extract that could be associated with anti-hyperglycemic activity. Of the three parts tested, every part indicates the potential α-glucosidase inhibitory activity and hexane extract of stem showed more inhibitory activity among all extracts. Thus, P . macrocarpa can attenuate hyperglycemia by potently inhibiting carbohydrate hydrolyzing enzymes, making it a viable plant as a source of natural compounds for the management of type 2 diabetes mellitus. Practical Application P . macrocarpa ( Scheff.) Boerl . belongs to the Thymelaeaceae family, which is known as ' Mahkota Dewa' is one of the well-known traditional herbs in South Asian countries. Every part of this plant has been reported to be used as a traditional medicine for diabetic treatment for many years. In the present study, the ability of this plant to inhibit carbohydrate hydrolyzing enzymes (α-glucosidase) was explored. All extracts tested exhibited the content to inhibit yeast α-glucosidase enzymes in vitro, and these beneficial effects appear to be due to some bioactive compounds in P . macrocarpa. Our preliminary investigation gives a principle for further animal and clinical studies of a possible use of P . macrocarpa for the management of diabetes mellitus. [ABSTRACT FROM AUTHOR]